1. Home
  2. SPRO vs IH Comparison

SPRO vs IH Comparison

Compare SPRO & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$2.28

Market Cap

124.5M

Sector

Health Care

ML Signal

HOLD

Logo iHuman Inc.

IH

iHuman Inc.

HOLD

Current Price

$1.74

Market Cap

116.0M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPRO
IH
Founded
2013
1996
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
124.5M
116.0M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
SPRO
IH
Price
$2.28
$1.74
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
337.6K
10.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
4.86%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$47,977,000.00
N/A
Revenue This Year
N/A
$39.02
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$7.30
Revenue Growth
N/A
N/A
52 Week Low
$0.51
$1.67
52 Week High
$3.09
$3.60

Technical Indicators

Market Signals
Indicator
SPRO
IH
Relative Strength Index (RSI) 49.92 44.42
Support Level $2.15 $1.79
Resistance Level $2.44 $3.12
Average True Range (ATR) 0.10 0.09
MACD -0.01 -0.00
Stochastic Oscillator 55.11 28.09

Price Performance

Historical Comparison
SPRO
IH

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.

Share on Social Networks: